The Assessment of Recovery Capital: Properties and psychometrics of a measure of addiction recovery strengths

Drug and Alcohol Review

Volumn 32, Issue 2, 2013, Pages 187-194

  Groshkova, Teodora ^a   Best, David ^b   White, William ^c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b MONASH UNIVERSITY   (Australia)

^c CHESTNUT HEALTH SYSTEMS   (United States)

Author keywords

Addiction; Assessment; Psychometrics; Recovery capital measure

Indexed keywords

ADDICTION; ADOLESCENT; ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEALTH BEHAVIOR; HUMAN; MALE; MIDDLE AGED; PILOT STUDY; PSYCHOMETRY; RANDOMIZED CONTROLLED TRIAL; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BEHAVIOR, ADDICTIVE; COHORT STUDIES; FEMALE; HEALTH BEHAVIOR; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; PSYCHOMETRICS; YOUNG ADULT;

EID: 84874938444     PISSN: 09595236     EISSN: 14653362     Source Type: Journal    
DOI: 10.1111/j.1465-3362.2012.00489.x     Document Type: Article

References (42)

1. Center for Substance Abuse Treatment (CSAT). National Summit on Recovery: Conference Report (DHHS Publication No. SMA 07-4276). Rockville, MD: Substance Abuse and Mental Health Services Administration, 2007.
2. Scottish Government. Road to recovery. Edinburgh: Scottish Government, 2008.
3. Government. Drug Strategy 2010-reducing demand, restricting supply, building recovery: supporting people to live a drug free life. London: HM Government, 2010.
4. White WL. Recovery: old wine, flavor of the month or new organizing paradigm? Subst Use Misuse 2008;43:1987-2000.
5. McLellan AT, Lewis DC, O'Brien CP, Kleber HD. Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA 2000;284:1689-1695.
6. Dennis M, Scott CK. Managing addiction as a chronic condition. Addict Sci Clin Pract 2007;4:45-55.
7. White W. Recovery management and recovery-oriented systems of care: scientific rationale and promising practices. Pittsburgh, PA: Northeast Addiction Technology Transfer Center, Great Lakes Addiction Technology Transfer Center, Philadelphia Department of Behavioral Health & Mental Retardation Services, 2008.
8. UK Drug Policy Commission. Recovery consensus Statement, 2008. Available at: http://www.ukdpc.org.uk/resources/avisionofrecovery.pdf (accessed July 2011).
9. Betty Ford Institute Consensus Panel. What is recovery? A working definition from the Betty Ford Institute. J Subst Abuse Treat 2007;33:221-228.
10. McLellan T. What is recovery? Revisiting the Betty Ford Institute Consensus Panel definition: the Betty Ford Consensus Panel and Consultants. J Subst Abuse Treat 2010;38:200-201.
11. Smith KW, Larson MJ. Quality of life assessments by adult substance abusers receiving publicly funded treatment in Massachusetts. Am J Drug Alcohol Abuse 2003;29: 323-335.
12. Donovan D, Mattson ME, Cisler RA, Longabaugh R, Zweben A. Quality of life as an outcome measure in alcoholism treatment research. J Stud Alcohol Suppl 2005;15:119-139. Discussion 92-3.
13. Foster JH, Peters TJ, Marshall EJ. Quality of life measures and outcome in alcohol-dependent men and women. Alcohol 2000;22:45-52.
14. Dawson DA, Li TK, Chou SP, Grant BF. Transitions in and out of alcohol use disorders: their associations with conditional changes in quality of life over a 3-year follow-up interval. Alcohol Alcohol 2009;44:84-92.
15. Laudet AB, Morgen K, White WL. The role of social supports, spirituality, religiousness, life meaning and affiliation with 12-step fellowships in quality of life satisfaction among individuals in recovery from alcohol and drug problems. Alcohol Treat Q 2006;24:33-73.
16. Laudet AB. The case for considering quality of life in addiction research and clinical practice. Addict Sci Clin Pract 2011;6:44-55.
17. Cloud W, Granfield R. Conceptualizing recovery capital: expansion of a theoretical construct. Subst Use Misuse 2008;43:1971-1986.
18. White W, Cloud W. Recovery capital: a primer for addictions professionals. Counselor 2008;9:22-27.
19. McLellan AT, Luborsky L, Woody GE, O'Brien CP. An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index. J Nerv Ment Dis 1980;168:26-33.
20. McLellan AT, Kushner H, Metzger D, etal. The Fifth Edition of the Addiction Severity Index. J Subst Abuse Treat 1992;9:199-213.
21. Marsden J, Gossop M, Stewart D, etal. The Maudsley Addiction Profile (MAP): a brief instrument for assessing treatment outcome. Addiction 1998;93:1857-1867.
22. Dennis ML, Titus JC, White M, Unsicker J, Hodgkins D. Global Appraisal of Individual Needs (GAIN): administration guide for the GAIN and related measures, Version 5th edn. Bloomington, IL: Chestnut Health Systems, 2003.
23. Brown BS, O'Grady KE, Battjes RJ, Katz EC. The Community Assessment Inventory-client views of supports to drug abuse treatment. J Subst Abuse Treat 2004;27:241-251.
24. Sterling R, Slusher C, Weinstein S. Measuring recovery capital and determining its relationship to outcome in an alcohol dependent sample. Am J Drug Alcohol Abuse 2008;34:603-610.
25. Simpson DD, Sells SB. Opioid addiction and treatment: a 12-year follow-up. Malabar, FL: Robert E. Krieger Publishing Company, 1990.
26. Gossop M, Marsden J, Stewart D, Treacy S. Outcomes after methadone maintenance and methadone reduction treatments: two-year follow-up results from the National Treatment Outcome Research Study. Drug Alcohol Depend 2001;62:255-264.
27. Gossop M, Marsden J, Stewart D, Kidd T. The National Treatment Outcome Research Study (NTORS): 4-5year follow-up results. Addiction 2003;98:291-303.
28. Best D, Honor S, Campbell A. Segmentation study report. London: NTA Recovery Oriented Drug Treatment Programme, 2011.
29. The WHOQOL Group. Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychol Med 1998;28:551-558.
30. World Health Organisation. The World Health Organisation Quality of Life-WHOQOL BREF 2004. Available at: http://www.who.int/substance_abuse/research_tools/en/english_whoqol.pdf (accessed July 2011).
31. Marsden J, Farrell M, Bradbury C, etal. Development of the treatment outcomes profile. Addiction 2008;103:1450-1460.
32. Koepsell TD, Weiss NS. Epidemiologic methods: studying the occurrence of illness. New York: Oxford University Press Inc, 2003.
33. Skevington SM, Lotfy M, O'Connell KA, WHOQOL Group. The World Health Organization's WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL group. Qual Life Res 2004;13:299-310.
34. Jolliffe IT. Principal component analysis, 2nd edn. Springer Series in Statistics. New York: Springer-Verlag, 2002.
35. Kline P. A psychometric primer. London: Free Association Books, 2000.
36. Perkins NJ, Schisterman EF. The inconsistency of 'optimal' cutpoints obtained using two criteria based on the receiver operating characteristic curve. Am J Epidemiol 2006;163:670-675.
37. Fluss R, Faraggi D, Reiser B. Estimation of the Youden Index and its associated cutoff point. Biom J 2005;47:458-472.
38. Howell DC. Statistical methods for psychology, 6th edn. Belmont, CA: Thomson Wadsworth, 2007.
39. Grissom RJ. Heterogeneity of variance in clinical data. J Consult Clin Psychol 2000;68:155-165.
40. Darke S, Hall W, Wodak A, Heather N, Ward J. Development and validation of a multi-dimensional instrument for assessing outcome of treatment among opiate users: the Opiate Treatment Index. Br J Addict 1992;87:733-742.
41. White W, Torres L. Recovery-oriented methadone maintenance. Chicago, IL: Great Lakes Addiction Technology Transfer Center, Philadelphia Department of Behavioral Health and Mental Retardation Services and Northeast Addiction Technology Transfer Center, 2010.
42. Best D, Groshkova T, Loaring J, Ghufran G, Day E, Taylor A. Comparing the addiction careers of heroin and alcohol users, and their self- reported reasons for achieving abstinence. J Groups Addict Recovery 2010;5:289-305.